Effect of VKORC1, CYP2C9, CYP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients (vol 20, pg 393, 2016)

被引：1
|
作者：
Wakamiya, Takuya [1 ]
Hokosaki, Tatsunori [1 ]
Tsujimoto, Shin-ichi [1 ]
Kadota, Keisuke [1 ]
Nakano, Yusuke [1 ]
Watanabe, Shigeo [1 ]
Iwamoto, Mari [1 ]
Yanagimachi, Masakatsu [1 ]
Ito, Shuichi [1 ]
机构：
[1] Yokohama City Univ, Sch Med, Dept Pediat, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan
来源：
MOLECULAR DIAGNOSIS & THERAPY | 2016年 / 20卷 / 05期
关键词：
D O I：
10.1007/s40291-016-0228-x
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：501 / 501
页数：1
相关论文
共 50 条
  • [31] Influence of CYP2C9, VKORC1, and CYP4F2 polymorphisms on the pharmacodynamic parameters of warfarin: a cross-sectional study
    Kannan Sridharan
    Rashed Al Banna
    Zainab Malalla
    Aysha Husain
    Mai Sater
    Ghufran Jassim
    Sameer Otoom
    [J]. Pharmacological Reports, 2021, 73 : 1405 - 1417
  • [32] Effect of VKORC1 and CYP2C9 polymorphisms on warfarin dose requirement in Bangladeshi population
    Chowdhury, Zahid Sadek
    Shahjin, Farah
    Akter, Farhana
    Ahmed, Maizbha Uddin
    Islam, Mohammad Safiqul
    Bin Sayeed, Muhammad Shandaat
    Islam, Reazul
    Hasnat, Abul
    [J]. PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 30 (02) : 341 - 346
  • [33] VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients
    Ozgon, G. Oner
    Langaee, T. Y.
    Feng, H.
    Buyru, N.
    Ulutin, T.
    Hatemi, A. C.
    Siva, A.
    Saip, S.
    Johnson, J. A.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (09) : 889 - 894
  • [34] VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients
    G. Oner Ozgon
    T. Y. Langaee
    H. Feng
    N. Buyru
    T. Ulutin
    A. C. Hatemi
    A. Siva
    S. Saip
    J. A. Johnson
    [J]. European Journal of Clinical Pharmacology, 2008, 64 : 889 - 894
  • [35] Prosthetic valve thrombosis - association of genetic polymorphisms of VKORC1, CYP2C9 and CYP4F2 genes
    Kalpana, S. R.
    Bharath, G.
    Jain, Simran
    Moorthy, Nagaraja
    Manjunath, Satvic C.
    Christopher, Rita
    [J]. MEDICINE, 2019, 98 (06)
  • [36] GENETIC POLYMORPHISMS OF VKORC1, CYP2C9, CYP4F2 IN BAI-, ZANG-CHINESE
    Tao, Ceng Wu
    [J]. HEART, 2011, 97
  • [37] PHARMACOGENOMIC VARIANTS OF CYP2C9, CYP4F2 AND VKORC1 AND ITS RELATION TO WARFARIN RESPONSE IN NATIVE OMANI PATIENTS
    Pathare, A.
    AlZadjali, S.
    Misquith, R.
    Gravell, D.
    Al Falahi, K.
    Al-Haddabi, H.
    Krishnamoorthy, R.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 668 - 668
  • [38] Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients
    Ye, Changqing
    Jin, Haiqiang
    Zhang, Rui
    Sun, Yongan
    Wang, Zhaoxia
    Sun, Weiping
    Sun, Wei
    Peng, Qing
    Liu, Ran
    Huang, Yining
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2014, 42 (01) : 67 - 76
  • [39] The effects of CYP2C9 and VKORC1 gene polymorphisms on warfarin maintenance dose in Turkish cardiac patients
    Akdeniz, Cansu Selcan
    Cevik, Mehtap
    Canbolat, Ismail Polat
    Yurdakul, Selen
    Cagatay, Penbe
    Ciftci, Cavlan
    Karaalp, Atila
    Susleyici, Belgin
    [J]. FUTURE CARDIOLOGY, 2020, 16 (06) : 645 - 654
  • [40] THE INFLUENCE OF CYP2C9 AND VKORC1 GENE POLYMORPHISMS ON THE RESPONSE TO WARFARIN IN EGYPTIANS
    Bedewy, A.
    Showeta, S.
    Hasan, M.
    Kandil, L.
    [J]. HAEMATOLOGICA, 2015, 100 : 801 - 802
12345